Antitumour effect of cyclin-dependent kinase inhibitors (p16(INK4A), p18(INK4C), p19(INK4D), p21(WAF1/CIP1) and p27(KIP1)) on malignant glioma cells

Cyclin-dependent kinase inhibitors (CDKIs) are considered as novel anticancer agents because of their ability to induce growth arrest or apoptosis in tumour cells. It has not yet been fully determined, however, which CDKI is the best candidate for the treatment of malignant gliomas and whether norma...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Komata, T, Kanzawa, T, Takeuchi, H, Germano, I M, Schreiber, M, Kondo, Y, Kondo, S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2003
Aiheet:
Experimental Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747579/
https://ncbi.nlm.nih.gov/pubmed/12698196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600862
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia